Neurological Research

Neurological Research is a peer-reviewed English journal published by Taylor & Francis, founded in 1979 and issued today from Abingdon for clinicians and scientists who work on diseases of the nervous system. Its remit joins basic and clinical research across neurosurgery, neurology, neuroengineering and the neurosciences, and the 2025 Journal Impact Factor is 1.9, Q3 in Clinical Neurology at 201 of 296.《神经病学研究》是 Taylor & Francis 出版的英文同行评审期刊，1979 年创刊，如今在 Abingdon 编辑发行，读者是研究神经系统疾病的临床医生与科学家。刊物把神经外科、神经病学、神经工程与神经科学的基础研究和临床研究并在一处，2025 年影响因子为 1.9，在临床神经病学类目列 Q3，排名 201/296。

Two features mark it out inside a crowded clinical neurology field. The first is a surgical centre of gravity, since endovascular and operative subjects that general neurology titles rarely carry appear here in quantity. The second is the habit of printing laboratory work beside its bedside counterpart, with 259 papers in the 2025 count resting on a literature cited 4507 times and a cited half-life of nine years.在拥挤的临床神经病学领域里，它有两处显眼。一是外科的重心，血管内与手术题材在一般神经病学期刊上少见，这里却成规模出现。二是把实验室工作与床旁工作并排刊出的习惯，2025 年统计 259 篇论文，全刊累计被引 4507 次，引用半衰期 9 年。

Scope

• The stated remit is basic and clinical research in four named fields, neurosurgery, neurology, neuroengineering and the neurosciences, and the journal asks for work whose implications run past the author's own subspecialty.宗旨写明的范围是四个领域的基础与临床研究，即神经外科、神经病学、神经工程与神经科学，刊物要求来稿的意义超出自家的亚专科。
• Stem cell applications head the topic list, covering transplantation after ischaemic injury, repair strategies for the contused spinal cord and dopaminergic grafting in Parkinsonian models.干细胞应用列在方向清单之首，涵盖缺血损伤后的移植、挫伤脊髓的修复策略，以及帕金森病模型里的多巴胺能移植。
• Molecular neuroscience supplies the mechanistic layer, through receptor pharmacology, transcriptional programmes that follow injury, axonal guidance and the molecular pathology of neurodegeneration.分子神经科学提供机制层面的内容，受体药理学、损伤后的转录程序、轴突导向与神经退变的分子病理都属于这一层。
• Neuropharmacology is handled as a clinical subject as much as a laboratory one, so antiepileptic dosing, neuroprotective agents and delivery across the blood-brain barrier sit in the same part of the journal.神经药理学既按临床题目处理，也按实验室题目处理，抗癫痫药的给药方案、神经保护剂，以及跨血脑屏障的递送，都归在刊物的同一处。
• Neurochemistry brings cerebrospinal fluid markers, transmitter turnover, oxidative stress and metabolic profiling, and such work often supplies the outcome measures used by clinical papers nearby.神经化学带来脑脊液标志物、递质周转、氧化应激与代谢谱分析，这类工作常为邻近的临床论文提供结局指标。
• Neuroradiology covers computed tomography, magnetic resonance imaging, diffusion and perfusion sequences, and the use of imaging as a surrogate endpoint in trials of stroke and of tumour treatment.神经放射学覆盖计算机断层扫描、磁共振成像、弥散与灌注序列，以及把影像当作卒中与肿瘤治疗试验替代终点的用法。
• Biomathematical models are named outright, which draws in compartmental modelling of drug kinetics, computational fluid dynamics applied to aneurysms and statistical models that predict functional outcome after haemorrhage.生物数学模型被单列成项，药物动力学的房室建模、用于动脉瘤的计算流体力学，以及预测出血后功能结局的统计模型因此有位置。
• Endovascular neurosurgery is the largest single strand, taking in coil embolisation, flow diversion, mechanical thrombectomy, embolisation of arteriovenous malformations and the periprocedural complications that follow each.血管内神经外科是最大的一支，弹簧圈栓塞、血流导向、机械取栓、动静脉畸形栓塞，以及各自的围手术期并发症都在其中。
• Innovation in neurosurgery closes the official list as an open category, holding new devices, intraoperative monitoring, minimally invasive corridors, robotic assistance and the first clinical series that report them.神经外科创新以开放类别的形式收束这份清单，新器械、术中监测、微创入路、机器人辅助，以及首次报告这些技术的临床系列都收在此处。
• Clinical neurology arrives through the wider labels rather than a heading of its own, so stroke, epilepsy, movement disorder and neuromuscular series appear whenever the evidence is strong enough to alter practice.临床神经病学经由较宽的标签进入，不单设栏目，只要证据足以改动做法，卒中、癫痫、运动障碍与神经肌肉疾病的系列研究就会出现。
• Tumour work enters by two doors, through surgical series on resection and through imaging studies on grading and follow-up, while glioma biology tends to appear under molecular neuroscience.肿瘤研究有两道门，一道是切除的手术系列，一道是分级与随访的影像研究，胶质瘤生物学则多出现在分子神经科学名下。
• Neuroengineering is written into the remit and carries brain-computer interfaces, neuromodulation hardware, deep brain stimulation programming and the signal processing that makes such devices usable in clinic.神经工程写在宗旨里，承载脑机接口、神经调控硬件、脑深部电刺激的参数设定，以及让这类器械能进临床的信号处理。
• The translational expectation is stated plainly. A paper should show why a laboratory finding matters at the bedside, and a technical report with no clinical bearing falls outside the declared interest.转化的期待写得直白，论文须说明实验室发现如何回到床旁，与临床无关的技术报告落在宗旨所划的兴趣之外。
• The readership is drawn widely, and the aims tell authors the journal exists for those who want to follow relevant experience in related and more distant fields, which rewards plain statement over technical display.读者面铺得宽，宗旨告诉作者刊物是给那些想了解相关领域乃至较远领域经验的人看的，平实的陈述因此比技术炫示更受待见。

History

• Volume 1 is dated 1979 and came out in New York under Crane, Russak and Company, an independent medical publisher, with two issues in that year and two more following in 1980.第 1 卷标为 1979 年，由纽约的独立医学出版社 Crane，Russak 出版，当年出两期，另两期到 1980 年才补齐。
• A quarterly rhythm held for more than a decade. Volumes 5 to 13, from 1983 to 1991, carry four numbers each, with volume 6 folding its first two into one issue, and volume 4 in 1982 paired its issues as 1-2 and 3-4.季刊的节奏维持了十多年，第 5 卷至第 13 卷覆盖 1983 年至 1991 年，每卷四个期号，第 6 卷把前两期并成一册，1982 年的第 4 卷也把期号并成 1-2 与 3-4。
• Frequency then climbed in steps. Volume 14 reached five numbers in 1992, volume 15 six in 1993, and volumes 20 to 24 at the turn of the century settled at eight regular numbers, with supplements in some years and a combined 2-3 issue in 2001.刊期随后逐级加密，第 14 卷在 1992 年到五期，第 15 卷在 1993 年到六期，世纪之交的第 20 卷至第 24 卷定为八期常规，个别年份另加增刊，2001 年把第 2 期与第 3 期并成一期。
• Ownership moved to Maney Publishing of Leeds, and the publisher field of records from the 2000s and 2010s carries that firm's address in the city rather than a New York one.产权转到利兹的 Maney Publishing，2000 年代与 2010 年代记录的出版方栏里登记的是这家公司在利兹的地址，不再是纽约的地址。
• Volume 30, dated 2008, is the first with ten numbers, and national library records, which date the change from 2009, still describe the title as ten issues a year.标为 2008 年的第 30 卷首次编满十期，国家医学图书馆把这次改动记在 2009 年，至今仍按每年十期标注。
• Twelve issues a volume began with volume 36, whose numbers run from late 2013 into 2014, and every volume since has kept one volume to a year with a monthly cover date.每卷十二期自第 36 卷开始，该卷的期号从 2013 年末跨到 2014 年，此后的卷次都保持一年一卷、按月标注出版月份。
• Taylor & Francis bought Maney Publishing in 2015, and the transfer is legible in the imprint, which reads Abingdon, Taylor & Francis from 2016 onward.Taylor & Francis 于 2015 年收购 Maney Publishing，交接在刊记上留痕，2016 年起的出版地记作 Abingdon，出版方写作 Taylor & Francis。
• The identifier prefix changed with the same move. Items from 2015 still carry 10.1179 in the main, new deposits take 10.1080, and by 2016 the new prefix is universal.标识符前缀随这次交接更换，2015 年的条目多数仍是 10.1179，新登记的改用 10.1080，到 2016 年已全部换成新前缀。
• Volume numbering has never restarted. Volume 1 belongs to 1979 and volume 47 to 2025, so the count runs straight through forty-seven years and volume 48 is being filled in 2026.卷号从未重起，第 1 卷属 1979 年，第 47 卷属 2025 年，编号直贯四十七年，第 48 卷正在 2026 年编定。
• MEDLINE and PubMed have covered the journal from volume 1, number 1, while Index Medicus carried it in print, which is why the 1979 papers are still easy to retrieve.MEDLINE 与 PubMed 自第 1 卷第 1 期起收录，Index Medicus 的纸本也收过，1979 年的论文因此至今容易检索。
• The impact factor rose to 2.448 in 2021 and 2.529 in 2022, fell to 1.7 in 2023 and 1.5 in 2024, then recovered to 1.9 in 2025.影响因子在 2021 年升到 2.448，2022 年为 2.529，2023 年落到 1.7，2024 年为 1.5，2025 年回到 1.9。
• The 2025 edition places it Q3 in Clinical Neurology at 201 of 296 and Q4 in Neurosciences at 266 of 330, a standing that fits a journal read mainly by practising clinicians.2025 年版把它列在临床神经病学 Q3，排名 201/296，神经科学 Q4，排名 266/330，这个位置与一份主要由临床医生阅读的刊物相称。
• Output holds near 259 papers a year, and the whole run has drawn 4507 citations with a cited half-life of nine years, long for a title that publishes at this size.年发文量维持在 259 篇上下，全刊累计被引 4507 次，引用半衰期 9 年，以这样的发文体量而言已经算长。
• Access has stayed on subscription. Gold open access accounts for 2.85 per cent of the 2025 output, so the title has never converted to a fully open model.获取方式一直是订阅制，2025 年金色开放获取占 2.85%，刊物从未转为完全开放的模式。
• The place of publication has shifted twice, from New York to Leeds and then to Abingdon, and the national library now files the title under England.出版地搬过两次，从纽约到利兹，再到 Abingdon，国家医学图书馆如今把刊物归在英格兰名下。

Editors

• Editorial correspondence runs through the publisher's Abingdon office at 2-4 Park Square, Milton Park, the address the title's own record gives for the journal.编辑部通信走出版方在 Abingdon 的办公室，地址是 Milton Park 的 2-4 Park Square，这也是刊物记录里给出的地址。
• Manuscripts move through Editorial Manager, the web system the author pages point to, so a paper keeps one record from first submission through revision to acceptance.稿件在 Editorial Manager 里流转，这是作者页面指向的在线系统，一份论文从首次投稿到修回直至录用都留在同一条记录里。
• The journal calls itself international and peer reviewed, and referees' reports, rather than the editorial office alone, decide what is accepted.刊物自称为国际性同行评审期刊，决定录用的是评审人的报告，编辑办公室并不单独定夺。
• Screening follows the division written into the aims. A submission is read first as laboratory work or as clinical work, and the two are weighed by different standards of evidence.初审顺着宗旨里写下的划分展开，稿件先被认作实验室工作或临床工作，两者按不同的证据标准衡量。
• The test applied at that stage is reach. Papers must interest readers in related and more distant fields, and a result intelligible only inside one subspecialty fits badly.这一步用的尺度是覆盖面，论文须让相关领域乃至较远领域的读者看得懂，只在单一亚专科内成立的结果并不合用。
• Subject coverage is organised by the eight named areas, which also serve as the map along which referees are picked, from stem cell work to endovascular technique.学科覆盖按八个列名方向组织，这份清单同时也是挑选评审人的地图，从干细胞工作一直到血管内技术。
• Themed issues have been a standing device. Between 2002 and 2011 the journal printed a run of guest editorials that opened special sections, each signed by the invited editor who assembled it.主题辑是常设手法，2002 年至 2011 年间刊物连续刊出客座社论，为专辑开篇，署名者是受邀组稿的编辑。
• One such section, the second issue on experimental subarachnoid haemorrhage, was introduced in 2006 by John H. Zhang and gathered work on cerebral vasospasm from several laboratories.其中一辑是实验性蛛网膜下腔出血的第二期专辑，（John H. Zhang）在 2006 年为它作序，汇集了几个实验室对脑血管痉挛的研究。
• Guest editorship has also carried narrower subjects. Molecular neuromyology was the theme Ugo Carraro introduced in 2010, and Jeffrey A. Brown signed two guest editorials in 2003.客座编辑也承担较窄的题目，分子神经肌学一组由（Ugo Carraro）在 2010 年引出，（Jeffrey A. Brown）在 2003 年连写两篇客座社论。
• Regional practice has had its own slot. A 2008 editorial by Liping Liu, Yongjun Wang and Yuchuan Ding reported the progress of stroke prevention and treatment in China.区域实践另有一席，（Liping Liu）、（Yongjun Wang）与（Yuchuan Ding）在 2008 年合写社论，报告中国卒中防治的进展。
• Long-form review keeps a place too. The 1997 pallidotomy review by Patricia Fernandez and Manuel Dujovny ran as an editorial review rather than as a standard article.长篇综述也留有一席，（Patricia Fernandez）与（Manuel Dujovny）1997 年的苍白球切开术综述以编辑综述的面目刊出，不按一般论文处理。